216 related articles for article (PubMed ID: 28137769)
1. Combined PET Imaging of the Inflammatory Tumor Microenvironment Identifies Margins of Unique Radiotracer Uptake.
Zinnhardt B; Pigeon H; Thézé B; Viel T; Wachsmuth L; Fricke IB; Schelhaas S; Honold L; Schwegmann K; Wagner S; Faust A; Faber C; Kuhlmann MT; Hermann S; Schäfers M; Winkeler A; Jacobs AH
Cancer Res; 2017 Apr; 77(8):1831-1841. PubMed ID: 28137769
[TBL] [Abstract][Full Text] [Related]
2. TSPO-PET and diffusion-weighted MRI for imaging a mouse model of infiltrative human glioma.
Pigeon H; Pérès EA; Truillet C; Jego B; Boumezbeur F; Caillé F; Zinnhardt B; Jacobs AH; Le Bihan D; Winkeler A
Neuro Oncol; 2019 Jun; 21(6):755-764. PubMed ID: 30721979
[TBL] [Abstract][Full Text] [Related]
3. TSPO imaging-guided characterization of the immunosuppressive myeloid tumor microenvironment in patients with malignant glioma.
Zinnhardt B; Müther M; Roll W; Backhaus P; Jeibmann A; Foray C; Barca C; Döring C; Tavitian B; Dollé F; Weckesser M; Winkeler A; Hermann S; Wagner S; Wiendl H; Stummer W; Jacobs AH; Schäfers M; Grauer OM
Neuro Oncol; 2020 Jul; 22(7):1030-1043. PubMed ID: 32047908
[TBL] [Abstract][Full Text] [Related]
4. Imaging temozolomide-induced changes in the myeloid glioma microenvironment.
Foray C; Valtorta S; Barca C; Winkeler A; Roll W; Müther M; Wagner S; Gardner ML; Hermann S; Schäfers M; Grauer OM; Moresco RM; Zinnhardt B; Jacobs AH
Theranostics; 2021; 11(5):2020-2033. PubMed ID: 33500706
[No Abstract] [Full Text] [Related]
5. Interrogating Glioma-Associated Microglia and Macrophage Dynamics Under CSF-1R Therapy with Multitracer In Vivo PET/MRI.
Foray C; Barca C; Winkeler A; Wagner S; Hermann S; Schäfers M; Grauer OM; Zinnhardt B; Jacobs AH
J Nucl Med; 2022 Sep; 63(9):1386-1393. PubMed ID: 35115369
[TBL] [Abstract][Full Text] [Related]
6. The translocator protein ligand [¹⁸F]DPA-714 images glioma and activated microglia in vivo.
Winkeler A; Boisgard R; Awde AR; Dubois A; Thézé B; Zheng J; Ciobanu L; Dollé F; Viel T; Jacobs AH; Tavitian B
Eur J Nucl Med Mol Imaging; 2012 May; 39(5):811-23. PubMed ID: 22270507
[TBL] [Abstract][Full Text] [Related]
7. Quantitative preclinical imaging of TSPO expression in glioma using N,N-diethyl-2-(2-(4-(2-18F-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide.
Tang D; Hight MR; McKinley ET; Fu A; Buck JR; Smith RA; Tantawy MN; Peterson TE; Colvin DC; Ansari MS; Nickels M; Manning HC
J Nucl Med; 2012 Feb; 53(2):287-94. PubMed ID: 22251555
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the inflammatory post-ischemic tissue by full volumetric analysis of a multimodal imaging dataset.
Barca C; Foray C; Hermann S; Döring C; Schäfers M; Jacobs AH; Zinnhardt B
Neuroimage; 2020 Nov; 222():117217. PubMed ID: 32745676
[TBL] [Abstract][Full Text] [Related]
9. Preclinical imaging evaluation of novel TSPO-PET ligand 2-(5,7-Diethyl-2-(4-(2-[(18)F]fluoroethoxy)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)-N,N-diethylacetamide ([ (18)F]VUIIS1008) in glioma.
Tang D; Nickels ML; Tantawy MN; Buck JR; Manning HC
Mol Imaging Biol; 2014 Dec; 16(6):813-20. PubMed ID: 24845529
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F
World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307
[TBL] [Abstract][Full Text] [Related]
11. The translocator protein radioligand 18F-DPA-714 monitors antitumor effect of erufosine in a rat 9L intracranial glioma model.
Awde AR; Boisgard R; Thézé B; Dubois A; Zheng J; Dollé F; Jacobs AH; Tavitian B; Winkeler A
J Nucl Med; 2013 Dec; 54(12):2125-31. PubMed ID: 24212976
[TBL] [Abstract][Full Text] [Related]
12. Preclinical TSPO Ligand PET to Visualize Human Glioma Xenotransplants: A Preliminary Study.
Buck JR; McKinley ET; Fu A; Abel TW; Thompson RC; Chambless L; Watchmaker JM; Harty JP; Cooper MK; Manning HC
PLoS One; 2015; 10(10):e0141659. PubMed ID: 26517124
[TBL] [Abstract][Full Text] [Related]
13. Preclinical Evaluation of a Novel TSPO PET Ligand 2-(7-Butyl-2-(4-(2-[
Tang D; Li J; Nickels ML; Huang G; Cohen AS; Manning HC
Mol Imaging Biol; 2019 Feb; 21(1):113-121. PubMed ID: 29869061
[TBL] [Abstract][Full Text] [Related]
14. In vivo imaging and characterization of [(18)F]DPA-714, a potential new TSPO ligand, in mouse brain and peripheral tissues using small-animal PET.
Vicidomini C; Panico M; Greco A; Gargiulo S; Coda AR; Zannetti A; Gramanzini M; Roviello GN; Quarantelli M; Alfano B; Tavitian B; Dollé F; Salvatore M; Brunetti A; Pappatà S
Nucl Med Biol; 2015 Mar; 42(3):309-16. PubMed ID: 25537727
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of TSPO PET Ligands [
Tang D; Li J; Buck JR; Tantawy MN; Xia Y; Harp JM; Nickels ML; Meiler J; Manning HC
Mol Imaging Biol; 2017 Aug; 19(4):578-588. PubMed ID: 27853987
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 18F-FET PET and perfusion-weighted MR imaging: a PET/MR imaging hybrid study in patients with brain tumors.
Filss CP; Galldiks N; Stoffels G; Sabel M; Wittsack HJ; Turowski B; Antoch G; Zhang K; Fink GR; Coenen HH; Shah NJ; Herzog H; Langen KJ
J Nucl Med; 2014 Apr; 55(4):540-5. PubMed ID: 24578243
[TBL] [Abstract][Full Text] [Related]
17. TSPO PET signal using [
Quach S; Holzgreve A; Kaiser L; Unterrainer M; Dekorsy FJ; Nelwan DV; Bartos LM; Kirchleitner SV; Weller J; Weidner L; Niyazi M; Ruf VC; Herms J; Stöcklein S; Wetzel C; Riemenschneider MJ; V Baumgarten L; Thon N; Brendel M; Rupprecht R; Bartenstein P; Tonn JC; Albert NL
Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):859-869. PubMed ID: 36329288
[TBL] [Abstract][Full Text] [Related]
18. Imaging of the glioma microenvironment by TSPO PET.
Zinnhardt B; Roncaroli F; Foray C; Agushi E; Osrah B; Hugon G; Jacobs AH; Winkeler A
Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):174-185. PubMed ID: 33721063
[TBL] [Abstract][Full Text] [Related]
19. Spatial heterogeneity of low-grade gliomas at the capillary level: a PET study on tumor blood flow and amino acid uptake.
Wyss MT; Hofer S; Hefti M; Bärtschi E; Uhlmann C; Treyer V; Roelcke U
J Nucl Med; 2007 Jul; 48(7):1047-52. PubMed ID: 17574979
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
Wang HE; Wu SY; Chang CW; Liu RS; Hwang LC; Lee TW; Chen JC; Hwang JJ
Nucl Med Biol; 2005 May; 32(4):367-75. PubMed ID: 15878506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
